BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37203791)

  • 21. Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.
    Pincez T; Landry JR; Roussy M; Jouan L; Bilodeau M; Laramée L; Couture F; Sinnett D; Gendron P; Hébert J; Oligny L; Rouette A; Tran TH; Wilhelm BT; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2020 Feb; 59(2):125-130. PubMed ID: 31515871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
    Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
    Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
    Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
    Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia.
    Siegfried A; Masliah-Planchon J; Roux FE; Larrieu-Ciron D; Pierron G; Nicaise Y; Gambart M; Catalaa I; Péricart S; Dubucs C; Mohand-Oumoussa B; Tirode F; Bourdeaut F; Uro-Coste E
    Acta Neuropathol Commun; 2019 Dec; 7(1):220. PubMed ID: 31888756
    [No Abstract]   [Full Text] [Related]  

  • 25. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
    Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
    Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porocarcinoma with YAP1-NUTM1 fusion presenting as a NUT immunohistochemistry-positive lymph node metastasis.
    Christensen DJ; Tuluc M
    J Cutan Pathol; 2023 May; 50(5):410-414. PubMed ID: 36794976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic Features of CIC-NUTM1 Sarcomas, a New Molecular Variant of the Family of CIC-Fused Sarcomas.
    Le Loarer F; Pissaloux D; Watson S; Godfraind C; Galmiche-Rolland L; Silva K; Mayeur L; Italiano A; Michot A; Pierron G; Vasiljevic A; Ranchère-Vince D; Coindre JM; Tirode F
    Am J Surg Pathol; 2019 Feb; 43(2):268-276. PubMed ID: 30407212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion".
    Lebrun L; Allard-Demoustiez S; Gilis N; Van Campenhout C; Rodesch M; Roman C; Calò P; Lolli V; David P; Fricx C; De Witte O; Escande F; Maurage CA; Salmon I
    Acta Neuropathol Commun; 2023 Mar; 11(1):46. PubMed ID: 36934287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.
    McEvoy CR; Holliday H; Thio N; Mitchell C; Choong DY; Yellapu B; Leong HS; Xu H; Lade S; Browning J; Takano EA; Byrne DJ; Gill AJ; Duong CP; Li J; Fellowes AP; Fox SB; Swarbrick A; Prall OWJ
    Lab Invest; 2021 Jan; 101(1):26-37. PubMed ID: 32873880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcoma with MGA-NUTM1 fusion in the lung: an emerging entity.
    Goto T; Arai Y; Shibata T; Oyama T; Yoshida A
    Virchows Arch; 2020 Feb; 476(2):317-322. PubMed ID: 31385070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma.
    Tamura R; Nakaoka H; Yoshihara K; Mori Y; Yachida N; Nishikawa N; Motoyama T; Okuda S; Inoue I; Enomoto T
    Genes Chromosomes Cancer; 2018 Nov; 57(11):557-563. PubMed ID: 30338611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRD3-NUTM1-expressing NUT carcinoma of lung on endobronchial ultrasound-guided transbronchial needle aspiration cytology, a diagnostic pitfall.
    Aryal SC; Zia S; Rodgers S; Shen Y; Perry K; Yuan L
    Diagn Cytopathol; 2022 Feb; 50(2):E47-E53. PubMed ID: 34672128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal embryonal leucine zipper kinase immunoreactivity in atypical teratoid/rhabdoid tumors: a study of 50 cases.
    Ravindra N; Rao S; Arivazhagan A; Santosh V
    Childs Nerv Syst; 2021 Dec; 37(12):3769-3775. PubMed ID: 34611764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NUT Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker-The Role of RNA Sequencing in the Diagnostic Procedure.
    Gasljevic G; Matter MS; Blatnik O; Unk M; Dirnhofer S
    Int J Surg Pathol; 2022 May; 30(3):273-277. PubMed ID: 34738485
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel PARD3B-NUTM1 fusion in an aggressive primary CNS embryonal tumor in a young adult.
    Ko K; Kitani T; Harris BT; Anaizi AN; Solomon D; Perry A; Toretsky J; Ozdemirli M
    Acta Neuropathol Commun; 2020 Jul; 8(1):112. PubMed ID: 32680570
    [No Abstract]   [Full Text] [Related]  

  • 36. "Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.
    Shiota H; Elya JE; Alekseyenko AA; Chou PM; Gorman SA; Barbash O; Becht K; Danga K; Kuroda MI; Nardi V; French CA
    Mol Cancer Res; 2018 Dec; 16(12):1826-1833. PubMed ID: 30139738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CIC-NUTM1 Sarcomas Affecting the Spine.
    Yang S; Liu L; Yan Y; Jiang L; Han S; Shen D; Zhang B
    Arch Pathol Lab Med; 2022 Jun; 146(6):735-741. PubMed ID: 34525172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging entities in NUTM1-rearranged neoplasms.
    McEvoy CR; Fox SB; Prall OWJ
    Genes Chromosomes Cancer; 2020 Jun; 59(6):375-385. PubMed ID: 32060986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
    Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
    J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature.
    Wang H; Weiss VL; Hoffman RD; Abel T; Ho RH; Borinstein SC; Mannion K; Bridge JA; Black J; Liang J
    Head Neck Pathol; 2021 Mar; 15(1):236-243. PubMed ID: 32077054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.